skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Pharma Intelligence Logo
Search Icon Pharma Report StoreRecommendationsProduct loginProductLogin
Global Search Configuration
Datamonitor Healthcare attended the 2013 European Cancer Congress (ECCO 17-ESMO 38-ESTRO 32) which took place between 27 September and 1 October in Amsterdam, Netherlands.

Highlights from this whitepaper include:

Results from Kadcyla Phase III Trial, TH3RESA, and the impact this will have on the breast cancer market

Insight into BioMarin’s PARP inhibitor BMN-763 and it’s effectiveness for BRCA mutation-positive metastatic breast cancer patients

Find out the likelihood of trebananib/paclitaxel regimen being approved

The-European-Cancer-Congress
Download whitepaper

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free   : +1 888 670 8900  
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (20) 805 20700

Or please submit your inquiry via the form so that we can provide you the best possible customer service.
Contact Customer Services

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now:

Shop now